248 related articles for article (PubMed ID: 23328624)
21. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
[TBL] [Abstract][Full Text] [Related]
22. Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
Vascotto C; Lirussi L; Poletto M; Tiribelli M; Damiani D; Fabbro D; Damante G; Demple B; Colombo E; Tell G
Oncogene; 2014 May; 33(22):2876-87. PubMed ID: 23831574
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.
Luchinat E; Chiarella S; Franceschini M; Di Matteo A; Brunori M; Banci L; Federici L
FEBS J; 2018 Mar; 285(5):832-847. PubMed ID: 29283500
[TBL] [Abstract][Full Text] [Related]
24. APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process.
Vascotto C; Fantini D; Romanello M; Cesaratto L; Deganuto M; Leonardi A; Radicella JP; Kelley MR; D'Ambrosio C; Scaloni A; Quadrifoglio F; Tell G
Mol Cell Biol; 2009 Apr; 29(7):1834-54. PubMed ID: 19188445
[TBL] [Abstract][Full Text] [Related]
25. Nucleophosmin in Its Interaction with Ligands.
Cela I; Di Matteo A; Federici L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664415
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
27. N6L pseudopeptide interferes with nucleophosmin protein-protein interactions and sensitizes leukemic cells to chemotherapy.
De Cola A; Franceschini M; Di Matteo A; Colotti G; Celani R; Clemente E; Ippoliti R; Cimini AM; Dhez AC; Vallée B; Raineri F; Cascone I; Destouches D; De Laurenzi V; Courty J; Federici L
Cancer Lett; 2018 Jan; 412():272-282. PubMed ID: 29111347
[TBL] [Abstract][Full Text] [Related]
28. RNA-recognition motifs and glycine and arginine-rich region cooperatively regulate the nucleolar localization of nucleolin.
Okuwaki M; Saotome-Nakamura A; Yoshimura M; Saito S; Hirawake-Mogi H; Sekiya T; Nagata K
J Biochem; 2021 Feb; 169(1):87-100. PubMed ID: 32785674
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
30. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
Calo E; Gu B; Bowen ME; Aryan F; Zalc A; Liang J; Flynn RA; Swigut T; Chang HY; Attardi LD; Wysocka J
Nature; 2018 Feb; 554(7690):112-117. PubMed ID: 29364875
[TBL] [Abstract][Full Text] [Related]
31. The folding pathway of a functionally competent C-terminal domain of nucleophosmin: protein stability and denatured state residual structure.
Chiarella S; Federici L; Di Matteo A; Brunori M; Gianni S
Biochem Biophys Res Commun; 2013 May; 435(1):64-8. PubMed ID: 23618861
[TBL] [Abstract][Full Text] [Related]
32. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
33. New insights into the biology of acute myeloid leukemia with mutated NPM1.
Brunetti L; Gundry MC; Goodell MA
Int J Hematol; 2019 Aug; 110(2):150-160. PubMed ID: 30632059
[TBL] [Abstract][Full Text] [Related]
34. NPM1 exhibits structural and dynamic heterogeneity upon phase separation with the p14ARF tumor suppressor.
Gibbs E; Perrone B; Hassan A; Kümmerle R; Kriwacki R
J Magn Reson; 2020 Jan; 310():106646. PubMed ID: 31751897
[TBL] [Abstract][Full Text] [Related]
35. The function of DNA binding protein nucleophosmin in AAV replication.
Satkunanathan S; Thorpe R; Zhao Y
Virology; 2017 Oct; 510():46-54. PubMed ID: 28704696
[TBL] [Abstract][Full Text] [Related]
36. A novel histone H4 variant H4G regulates rDNA transcription in breast cancer.
Long M; Sun X; Shi W; Yanru A; Leung STC; Ding D; Cheema MS; MacPherson N; Nelson CJ; Ausio J; Yan Y; Ishibashi T
Nucleic Acids Res; 2019 Sep; 47(16):8399-8409. PubMed ID: 31219579
[TBL] [Abstract][Full Text] [Related]
37. Two novel NPM1 mutations in a therapy-responder AML patient.
Pianta A; Fabbro D; Damiani D; Tiribelli M; Fanin R; Franzoni A; Romanello M; Tell G; Di Loreto C; Damante G
Hematol Oncol; 2010 Sep; 28(3):151-5. PubMed ID: 19593743
[TBL] [Abstract][Full Text] [Related]
38. Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia.
Florio D; Roviello V; La Manna S; Napolitano F; Maria Malfitano A; Marasco D
Bioorg Chem; 2022 Oct; 127():106001. PubMed ID: 35803020
[TBL] [Abstract][Full Text] [Related]
39. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.
Li Z; Hann SR
Oncogene; 2013 Apr; 32(15):1988-94. PubMed ID: 22665062
[TBL] [Abstract][Full Text] [Related]
40. Structural investigation of nucleophosmin interaction with the tumor suppressor Fbw7γ.
Di Matteo A; Franceschini M; Paiardini A; Grottesi A; Chiarella S; Rocchio S; Di Natale C; Marasco D; Vitagliano L; Travaglini-Allocatelli C; Federici L
Oncogenesis; 2017 Sep; 6(9):e379. PubMed ID: 28920929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
